MMP9 and prostate cancer: Several studies reported the decrease in invasiveness and MMP-2/MMP-9-mediated migration in several breast cancer cell lines [212], in a cholangiocarcinoma cell line (30 μM) [241] and in a prostate cancer cell line (>5 μM) [242].